Comparison of the efficacy and safety of first-line treatments based on clinicopathological characteristics for patients with advanced epidermal growth factor receptor mutated non-small-cell lung cancer: A systematic review and network meta-analysis

A growing number of regimens have been approved as first-line treatments for patients with advanced epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer. However, the optimal regimen has not been determined, especially for patients with different clinicopathological characteris...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Critical reviews in oncology/hematology 2022-09, Vol.177, p.103760-103760, Article 103760
Hauptverfasser:	Yang, Fei, Zhang, Wengang, Shang, Xiaoling, Liu, Ni, Ma, Xinchun, Qin, Jing, Zhang, Yuqing, Liu, Yanguo, Wang, Xiuwen
Format:	Artikel
Sprache:	eng
Schlagworte:	Epidermal growth factor receptor First-line Network meta-analysis Non-small cell lung cancer Tyrosine kinase inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!